Effective and Affordable Flu Vaccines for the World

Informazioni relative al progetto

INDIGO

ID dell’accordo di sovvenzione: 874653

DOI

10.3030/874653

Data della firma CE 13 Dicembre 2019

Data di avvio 1 Aprile 2020

Data di completamento 31 Marzo 2026

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 16 000 968,00

Contributo UE

€ 9 975 979,00

Coordinato da

STICHTING AMSTERDAM UMC
Netherlands

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (4)

Report on status of posting results in the study registry TETRA-LITE Phase I (EU)

Report on the status of the results posting including timelines when final posting of results is scheduled after end of funding period of Phase I trial TETRA-LITE (EU).

Publication LVA and MDPA adjuvants on human PBMCs

Publication LVA and MDPA adjuvants on human PBMCs and DCs

Report/Publication protective immunity TETRA-LITE in ferrets

ReportPublication protective immunity TETRALITE in ferrets

Report/Publication mode of action LVA for CTA

ReportPublication mode of action LVA for CTA

Websites, patent fillings, videos etc. (1)

Website, Facebook, etc.

Website Facebook etc

Pubblicazioni

Peer reviewed articles (4)

Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells

Autori: Srinivasa Reddy Bonam, Peter Paul Platenburg and Jagadeesh Bayry
Pubblicato in: Frontiers Immunology, Numero 9 January 2023, 2023, ISSN 1664-3224
Editore: Frontiers in immunology

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo

Autori: Sneha Raj, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Ritika Khatri, Amit Kumar, Mrityunjay Singh, Surbhi Mishra, Shailendra Asthana, Shubbir Ahmed, Sweety Samal
Pubblicato in: Vaccines, Numero 11, 2023, Pagina/e 780, ISSN 2076-393X
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines11040780

Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study

Autori: Valentino D’Onofrio, Sharon Porrez, Bart Jacobs, Azhar Alhatemi, Fien De Boever, Gwenn Waerlop, Els Michels, Francesca Vanni, Alessandro Manenti, Geert Leroux-Roels, Peter Paul Platenburg, Luuk Hilgers, Isabel Leroux-Roels
Pubblicato in: Vaccines, Numero 12, 2024, Pagina/e 1036, ISSN 2076-393X
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines12091036

Carbohydrate fatty acid monosulphate ester is a potent adjuvant for low-dose seasonal influenza vaccines

Autori: Peter Paul L.I. Platenburg, Frantz Deschamps, Jennifer Jung, Clément Leonard, Séverine Rusconi, S.B. Mohan Kumar, S.M. Sulaiman, Leon de Waal, Luuk A. Th. Hilgers
Pubblicato in: Vaccine, Numero 41, 2023, Pagina/e 6980-6990, ISSN 0264-410X
Editore: Elsevier BV
DOI: 10.1016/j.vaccine.2023.10.017